210 related articles for article (PubMed ID: 7622206)
1. A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia.
Sato K; Yoo YC; Fukushima A; Saiki I; Takahashi TA; Fujihara M; Tono-Oka S; Azuma I
Infect Immun; 1995 Aug; 63(8):2859-66. PubMed ID: 7622206
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin antagonism by a synthetic lipid A analogue, DT-5461, with low endotoxicity in human peripheral blood monocytes.
Sato K; Fujihara M; Takahashi TA; Choon Yoo Y; Hata K; Tono-Oka S; Suzuki T; Sekiguchi S; Azuma I
Biochem Biophys Res Commun; 1995 Nov; 216(1):367-74. PubMed ID: 7488114
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.
Perera PY; Qureshi N; Christ WJ; Stütz P; Vogel SN
Infect Immun; 1998 Jun; 66(6):2562-9. PubMed ID: 9596717
[TBL] [Abstract][Full Text] [Related]
4. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
Matsuura M; Kiso M; Hasegawa A; Nakano M
Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
[TBL] [Abstract][Full Text] [Related]
5. Production of tumor necrosis factor induced by synthetic low-toxicity lipid A analog, DT-5461a, is mediated by LPS receptor sites and tyrosine kinase-MAP kinase signaling pathway in murine macrophages.
Joto N; Akimoto T; Someya K; Tohgo A
Cell Immunol; 1995 Jan; 160(1):1-7. PubMed ID: 7531115
[TBL] [Abstract][Full Text] [Related]
6. Antitumor synthetic lipid A analog DT-5461a upregulates cytokine expression in a murine macrophage cell line through LPS pathway.
Akahane K; Someya K; Tsutomi Y; Akimoto T; Tohgo A
Cell Immunol; 1994 Apr; 155(1):42-52. PubMed ID: 8168150
[TBL] [Abstract][Full Text] [Related]
7. Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.
Perera PY; Manthey CL; Stütz PL; Hildebrandt J; Vogel SN
Infect Immun; 1993 May; 61(5):2015-23. PubMed ID: 7683001
[TBL] [Abstract][Full Text] [Related]
8. A lipid A analog inhibits LPS-induced cytokine expression and improves survival in endotoxemic mice.
Someya K; Tsutomi Y; Soga T; Akahane K
Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):477-95. PubMed ID: 8933165
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation.
Akimoto T; Kumazawa E; Jimbo T; Joto N; Tohgo A
Int J Immunopharmacol; 1994 Nov; 16(11):887-93. PubMed ID: 7868293
[TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction.
Zuckerman SH; Qureshi N
Infect Immun; 1992 Jul; 60(7):2581-7. PubMed ID: 1612727
[TBL] [Abstract][Full Text] [Related]
11. Chemically detoxified lipid A precursor derivatives antagonize the TNF-alpha-inducing action of LPS in both murine macrophages and a human macrophage cell line.
Tanamoto K
J Immunol; 1995 Dec; 155(11):5391-6. PubMed ID: 7594555
[TBL] [Abstract][Full Text] [Related]
12. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.
Wang MH; Flad HD; Feist W; Musehold J; Kusumoto S; Brade H; Gerdes J; Rietschel HT; Ulmer AJ
Lymphokine Cytokine Res; 1992 Feb; 11(1):23-31. PubMed ID: 1576244
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipid A- and lipopolysaccharide-induced cytokine secretion, B cell mitogenesis, and lethal shock by lipid A-specific murine monoclonal antibodies.
Ramachandra RN; Berczi A; Sehon AH; Berczi I
J Infect Dis; 1993 May; 167(5):1151-9. PubMed ID: 8486948
[TBL] [Abstract][Full Text] [Related]
15. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.
Feist W; Ulmer AJ; Wang MH; Musehold J; Schlüter C; Gerdes J; Herzbeck H; Brade H; Kusumoto S; Diamantstein T
FEMS Microbiol Immunol; 1992 Jan; 4(2):73-89. PubMed ID: 1547025
[TBL] [Abstract][Full Text] [Related]
16. Induction of TNF-alpha and MnSOD by endotoxin: effect of E5531, a synthetic non-toxic lipid A analog.
White JE; Tsan MF
J Endotoxin Res; 2000; 6(4):329-35. PubMed ID: 11521054
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood.
Milano S; Arcoleo F; D'Agostino P; Cillari E
Antimicrob Agents Chemother; 1997 Jan; 41(1):117-21. PubMed ID: 8980766
[TBL] [Abstract][Full Text] [Related]
18. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.
Kirikae F; Kirikae T; Qureshi N; Takayama K; Morrison DC; Nakano M
Infect Immun; 1995 Feb; 63(2):486-97. PubMed ID: 7529746
[TBL] [Abstract][Full Text] [Related]
19. Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonist.
Kobayashi S; Kawata T; Kimura A; Miyamoto K; Katayama K; Yamatsu I; Rossignol DP; Christ WJ; Kishi Y
Antimicrob Agents Chemother; 1998 Nov; 42(11):2824-9. PubMed ID: 9797210
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral production of tumor necrosis factor augmented by endogenous interferons results in potent antitumor effects of DT-5461, a synthetic lipid A analog.
Kumazawa E; Akimoto T; Kita Y; Jimbo T; Joto N; Tohgo A
J Immunother Emphasis Tumor Immunol; 1995 Apr; 17(3):141-50. PubMed ID: 7542128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
